Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10.

[1]  M. Gougerot-Pocidalo,et al.  Régulation de l'explosion oxydative des polynucléaires neutrophiles humains par les cytokines pro- et anti-inflammatoires : Les Cytokines : de la Clinique à la Biologie ? , 2002 .

[2]  Y. Okada,et al.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis , 2000, Annals of the rheumatic diseases.

[3]  Hiroshi Tanaka,et al.  Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma. , 2000, The Journal of allergy and clinical immunology.

[4]  M. Estenne,et al.  Obliterative bronchiolitis after lung transplantation , 2000, Current opinion in pulmonary medicine.

[5]  Upregulation and interaction of TNFα and gelatinases A and B in painful peripheral nerve injury , 2000, Brain Research.

[6]  J. Wain,et al.  The history of lung transplantation. , 2000, Chest surgery clinics of North America.

[7]  R. Moqbel,et al.  Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. , 1999, The Journal of allergy and clinical immunology.

[8]  T. Casale,et al.  Combination of IL-8 plus TNF alpha induces additive neutrophil migration. , 1999, Allergy and asthma proceedings.

[9]  W. Busse,et al.  Airway remodeling and repair. , 1999, American journal of respiratory and critical care medicine.

[10]  G. Patterson,et al.  Lung transplantation: a decade of experience. , 1999, Annals of surgery.

[11]  K. Yoshino,et al.  Structure-activity relationship of hydroxamate-based inhibitors on membrane-bound Fas ligand and TNF-alpha processing. , 1999, Drug design and discovery.

[12]  Arthur S Slutsky,et al.  Upregulation of T-helper 1 cytokines and chemokine expression in post-transplant airway obliteration. , 1999, American journal of respiratory and critical care medicine.

[13]  A. Campana,et al.  Effects of tumour necrosis factor-α, interleukin-1 α, macrophage colony stimulating factor and transforming growth factor β on trophoblastic matrix metalloproteinases , 1999 .

[14]  C. Liang,et al.  Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. , 1999, American journal of respiratory cell and molecular biology.

[15]  K. Nabeshima,et al.  Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. , 1999, The American journal of pathology.

[16]  L. Boulet,et al.  Serum matrix metalloproteinase-9:Tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma. , 1999, American journal of respiratory and critical care medicine.

[17]  M. Klinnert,et al.  Interleukin-10 and transforming growth factor-β promoter polymorphisms in allergies and asthma , 1998 .

[18]  Y. Fukuda,et al.  Immunohistochemical and gelatin zymography studies for matrix metalloproteinases in bleomycin‐induced pulmonary fibrosis , 1998, Pathology international.

[19]  D Heng,et al.  Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  J. Bousquet,et al.  Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.

[21]  L. Wahl,et al.  Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. , 1998, Journal of immunology.

[22]  S. Maśliński,et al.  Ligation of selectin L and integrin CD11b/CD18 (Mac-1) induces release of gelatinase B (MMP-9) from human neutrophils , 1998, Inflammation Research.

[23]  F. Kelly,et al.  Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung. , 1998, The European respiratory journal.

[24]  I. Paradis.  Bronchiolitis obliterans: pathogenesis, prevention, and management. , 1998, The American journal of the medical sciences.

[25]  R. Novick,et al.  Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease , 1998, The Lancet.

[26]  C. Keller,et al.  Mixed (neutrophil-rich) interstitial pneumonitis in biopsy specimens of lung allografts: a clinicopathologic evaluation. , 1998, Chest.

[27]  F. Martinez,et al.  Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. , 1996, Journal of immunology.

[28]  R. Duranti,et al.  Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. , 1996, Thorax.

[29]  F. Hargreave,et al.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. , 1996, American journal of respiratory and critical care medicine.

[30]  M. Stearns,et al.  Cytokine (IL-10, IL-6) induction of tissue inhibitor of metalloproteinase 1 in primary human prostate tumor cell lines. , 1995, Oncology research.

[31]  W. Stetler-Stevenson,et al.  The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. , 1994, The European respiratory journal.

[32]  L. Garbe,et al.  Monitoring of alveolar macrophage production of tumor necrosis factor-alpha and interleukin-6 in lung transplant recipients. Marseille and Montreal Lung Transplantation Group. , 1994, American journal of respiratory and critical care medicine.

[33]  J. Castracane,et al.  THE PARTICIPATION OF TUMOR NECROSIS FACTOR IN THE PATHOGENESIS OF LUNG ALLOGRAFT REJECTION IN THE RAT , 1993, Transplantation.

[34]  R. Strieter,et al.  Lung allograft rejection: role of tumor necrosis factor-alpha and interleukin-6. , 1993, Chest.

[35]  G. Patterson,et al.  A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[36]  R. Mecham,et al.  Neutrophils show chemotaxis to type IV collagen and its 7S domain and contain a 67 kD type IV collagen binding protein with lectin properties. , 1989, American journal of respiratory cell and molecular biology.